因为这些公司的运作模式就是:以很低的价格购买大药企由于试验失败而已经放弃研发的药物。他们这么做的理由就是:我们就是比大药企更懂药物、更能解读失败试验。
问题是:你信么?
人家跨国大药企,雇...查看全文
医药魔方2016-11-01 18:16
10月27日,一家名叫Myovant Sciences的生物技术公司完成了IPO,以15美元/股的价格公开发行1450万股,成功募资2.18亿美元,成为2016年规模最大的一起生物技术公司IPO。其中辉瑞和欧洲健康投资机构BB Biotech分别出资3000万美元。
辉瑞作为领投,拥有与Myovant 的第一谈判权,且在Myovant 拥有一...查看全文
$Myovant Sciences(MYOV)$ 15-12G Securities registration termination [Section 12(g)] Accession Number: 0001140361-23-012511 Act: 34 Size: 11 KB 网页链接
$Myovant Sciences(MYOV)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-000587 Act: 33 Size: 1 KB 网页链接
$Myovant Sciences(MYOV)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-000586 Act: 33 Size: 1 KB 网页链接
$Myovant Sciences(MYOV)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0000876661-23-000191 Act: 34 Size: 4 KB 网页链接
$Myovant Sciences(MYOV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-017719 Size: 22 KB 网页链接
$Myovant Sciences(MYOV)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001140361-23-011049 Act: 33 Size: 20 KB 网页链接
$Myovant Sciences(MYOV)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001140361-23-011050 Act: 33 Size: 20 KB 网页链接
$Myovant Sciences(MYOV)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-23-066981 Act: 34 Size: 69 KB 网页链接
$Myovant Sciences(MYOV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-017720 Size: 18 KB 网页链接
$Myovant Sciences(MYOV)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-23-011051 Act: 33 Size: 21 KB 网页链接